Not All Weight Loss Is the Same

The scale is an honest instrument. It is also a limited one.

It can tell you how much total body weight changed. It cannot tell you what was lost, what was preserved, or whether you became stronger, weaker or functionally unchanged along the way.

That distinction is moving to the center of the GLP-1 conversation.

The question the scale cannot answer

Medication studies have become very good at reporting the quantity of weight loss. The harder and more important question is the quality of that weight loss.

A 20-pound reduction that comes primarily from fat, while strength and lean tissue are supported, is not the same outcome as a 20-pound reduction accompanied by declining strength, reduced physical capacity and substantial lean-mass loss.

The number on the scale may be identical. The body arriving at that number is not.

What the body-composition research now shows

A 2026 paper in the journal Obesity — “Glucagon-Like Peptide-1 Receptor Agonist-Based Agents and Body Composition: Filling More Gaps”, by Dubin and colleagues — reflects this shift. Rather than asking only how much weight people lose, it examines what the weight loss is made of.

Reviewing roughly 40 DXA-based reports—DXA being a body-composition scan that separates fat mass from fat-free mass—the authors found that the loss of fat-free mass with GLP-1-based agents sits in the upper range of what is expected from other non-surgical approaches to obesity.

In plain terms: meaningful fat loss, but a non-trivial share of the total can come from fat-free mass unless something is done to protect it.

This echoes earlier data. In an exploratory body-composition analysis from the STEP 1 semaglutide trial, participants lost substantially more fat mass but also experienced a reduction in total lean body mass.

One caveat matters. Fat-free mass and lean mass are not identical to skeletal muscle, and a measured drop does not automatically mean an equivalent loss of functional muscle. Hydration and other fat-free components affect the reading. But the pattern is consistent enough to take seriously.

Two identical numbers, two different bodies

This is why body weight alone is a poor scoreboard. Two people can lose the same amount and end up in very different places: one keeps the strength to climb stairs, carry groceries and stay independent; the other reaches a lower weight with less of the muscle that makes those things possible.

The scale cannot tell those two people apart. Strength performance can.

Training is what changes the composition of the loss

The medication drives the calorie deficit. Resistance training and adequate protein are the levers that influence how much of what you keep is muscle. They do not compete with the prescription; they shape the outcome it produces.

That is the premise of GLP Fitness. We do not treat body weight as the only scoreboard. We focus on the training side of the equation, using structured resistance training and strength performance to help people stay capable while their bodies change.

The next question

The next generation of GLP-1 research should not ask only, “How much weight did people lose?” It should also ask: What did they lose? What did they preserve? And what can they still do?

Weight loss is the outcome you see. Weight-loss quality is the outcome you live with.

Muscle is the metric.